Lifeline Biotechnologies LLBO Stock
Lifeline Biotechnologies Price Chart
Lifeline Biotechnologies LLBO Financial and Trading Overview
| Lifeline Biotechnologies stock price | 0.0001 USD |
| Previous Close | 0.0002 USD |
| Open | 0.0002 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0002 - 0.0002 USD |
| 52 Week Range | 0.0002 - 0.0005 USD |
| Volume | 1 USD |
| Avg. Volume | 424.05K USD |
| Market Cap | 10.99M USD |
| Beta (5Y Monthly) | -1.898591 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
LLBO Valuation Measures
| Enterprise Value | 461.65K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.099999994 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Lifeline Biotechnologies Stock Price History
| Beta (5Y Monthly) | -1.898591 |
| 52-Week Change | -33.33% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0005 USD |
| 52 Week Low | 0.0002 USD |
| 50-Day Moving Average | 0.000206 USD |
| 200-Day Moving Average | 0.0002895 USD |
LLBO Share Statistics
| Avg. Volume (3 month) | 424.05K USD |
| Avg. Daily Volume (10-Days) | 46.7K USD |
| Shares Outstanding | 0 |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1:150 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2009 |
| Most Recent Quarter (mrq) | December 31, 2009 |
| Next Fiscal Year End | December 31, 2010 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -574268 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 603.32K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 481.57K USD |
| Total Debt/Equity (mrq) | 7.89 USD |
| Current Ratio (mrq) | 8.424 |
| Book Value Per Share (mrq) | 0.002 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Lifeline Biotechnologies
| Country | United States |
| State | NV |
| City | Reno |
| Address | 1325 Airmotive Way |
| ZIP | 89502 |
| Phone | 775-852-3222 |
| Website | https://www.lbti.co |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. is headquartered in Reno, Nevada.
Q&A For Lifeline Biotechnologies Stock
What is a current LLBO stock price?
Lifeline Biotechnologies LLBO stock price today per share is 0.0001 USD.
How to purchase Lifeline Biotechnologies stock?
You can buy LLBO shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lifeline Biotechnologies?
The stock symbol or ticker of Lifeline Biotechnologies is LLBO.
Which industry does the Lifeline Biotechnologies company belong to?
The Lifeline Biotechnologies industry is Medical Devices.
How many shares does Lifeline Biotechnologies have in circulation?
The max supply of Lifeline Biotechnologies shares is 109.86B.
What is Lifeline Biotechnologies Price to Earnings Ratio (PE Ratio)?
Lifeline Biotechnologies PE Ratio is now.
What was Lifeline Biotechnologies earnings per share over the trailing 12 months (TTM)?
Lifeline Biotechnologies EPS is 0 USD over the trailing 12 months.
Which sector does the Lifeline Biotechnologies company belong to?
The Lifeline Biotechnologies sector is Healthcare.